Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisdexamfetamine for acute methamphetamine withdrawal
ACTRN12621000045819Phase 4Completed
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lisdexamfetamine in Stimulant Withdrawal and methamphetamine use disorder (MUD), sponsored by St Vincent's Hospital Sydney. Started Apr 2021; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
Stimulant Withdrawalmethamphetamine use disorder (MUD)
Beyond the preview
Go deeper on ACTRN12621000045819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000045819.